Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132694) titled 'Effects of Tegileridine Fumarate on Postoperative Analgesia and Gastrointestinal Function Recovery in Patients with Colorectal Tumors' on Sept. 17.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Lu'an People's Hospital
Condition:
Patients with colorectal tumors
Intervention:
Sufentanil group:Intravenous injection of Sufentanil 7.5 ug at the end of surgery
PCIA analgesic pump drug formulation: Add Sufentanil 0.5µg/ml to Dexamethasone 15mg and Ondansetron 16mg, configured with normal saline into a 100 ml solution
Background infusion of analgesic pump 3ml/h, self-controlled inf...